Pre-commercial biotech companies with large market caps in the U.S. 2017

Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*

by Matej Mikulic, last edited Dec 4, 2018
Pre-commercial biotech companies with large market caps in the U.S. 2017 This statistic depicts the market capitalization of pre-commercial biotechnology companies in the United States that have reached over one billion U.S. dollars as of March 2017. At this time, Puma Biotechnology had a market capitalization of 1.38 billion U.S. dollars.
Show more

Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*

Loading statistic...
Expand statistic
Market capitalization in million U.S. dollars
Alnylam Pharmaceuticals4,410
Kite Pharma**4,304
Neurocine Biosciences3,772
bluebird bio3,713
Ultragenyx Pharmaceutical**2,828
Sage Therapeutics**2,649
Agios Pharmaceuticals2,466
Intrexon2,353
Juno Therapeutics**2,353
Portola Pharmaceuticals2,216
AveXis2,109
Radius Health**1,669
Spark Therapeutics**1,656
FibroGen**1,575
Aerie Therapeutics1,525
Blueprint Medicines**1,524
Array Biopharma1,511
TherapeuticsMD1,422
Puma Biotechnology1,375
Emergent BioSolutions1,182
Market capitalization in million U.S. dollars
Alnylam Pharmaceuticals4,410
Kite Pharma**4,304
Neurocine Biosciences3,772
bluebird bio3,713
Ultragenyx Pharmaceutical**2,828
Sage Therapeutics**2,649
Agios Pharmaceuticals2,466
Intrexon2,353
Juno Therapeutics**2,353
Portola Pharmaceuticals2,216
AveXis2,109
Radius Health**1,669
Spark Therapeutics**1,656
FibroGen**1,575
Aerie Therapeutics1,525
Blueprint Medicines**1,524
Array Biopharma1,511
TherapeuticsMD1,422
Puma Biotechnology1,375
Emergent BioSolutions1,182
Download Settings Share
Download started
Please be patient - this may take a moment
by Matej Mikulic, last edited Dec 4, 2018
This statistic depicts the market capitalization of pre-commercial biotechnology companies in the United States that have reached over one billion U.S. dollars as of March 2017. At this time, Puma Biotechnology had a market capitalization of 1.38 billion U.S. dollars.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Biotech industry
Biotech industry

All Information
in one Presentation

Biotech industry

Everything On "Biotech industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Biotech industry"
  • Global overview
  • U.S. companies
  • Research & development
  • Products
  • Funding/investment
  • Biotech in agriculture
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.